Arrowstreet Capital
AEHR icon

Arrowstreet Capital’s Aehr Test Systems AEHR Stock Holding History

Arrowstreet Capital’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,602
Closed -$463K – 1206
2022
Q1 		$463K Sell
45,602
-292,521
-87% -$3.74M ﹤0.01% 1040
2021
Q4 		$8.18M Buy
+338,123
New +$6.61M 0.01% 701

Other funds holding AEHR

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital's AEHR Position: Q2 2022 in Review

Arrowstreet Capital sold out of Aehr Test Systems (AEHR) in Q2 2022, closing a stake of 45,602 shares — an estimated $463K sold.

Arrowstreet Capital first reported a position in AEHR in Q4 2021 and held it in 2 quarters. The position peaked at $8.18M in Q4 2021. 70 funds tracked by Wall St. Rank hold AEHR as of Q2 2022.

  • Arrowstreet Capital reported no remaining Aehr Test Systems position as of Q2 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 45,602 Aehr Test Systems shares in Q2 2022, an estimated $463K.
  • Arrowstreet Capital first reported a position in Aehr Test Systems in Q4 2021 and held it in 2 quarters.
  • Arrowstreet Capital's Aehr Test Systems position peaked at $8.18M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2022.

Based on Arrowstreet Capital's 13F filing for Q2 2022, filed 15 Aug 2022.